Cenobamate is used for partial-onset seizures in adults. Its adverse reactions involve multiple systems including allergic, cardiac, neurological, and psychiatric systems, requiring focused monitoring and prevention.

I. Serious Allergic and Cardiac-Related Adverse Reactions

1. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Also known as multiorgan hypersensitivity, it may involve the liver, kidneys, blood system, and other organs.

Typical manifestations include fever, rash, lymphadenopathy, and/or facial swelling.

It has occurred with rapid titration (weekly or faster), including one fatality.

If a serious allergic reaction is suspected, the drug should be discontinued immediately and medical attention sought.

2. QT Interval Shortening

Cenobamate may cause dose-dependent QT interval shortening.

It is contraindicated in patients with familial short QT syndrome.

Concomitant use with other drugs that shorten the QT interval may produce synergistic effects and increase risk.

During treatment, patients should inform their doctor of all concomitant medications and be alert for symptoms such as palpitations and syncope.

II. Neurological and Psychiatric-Related Adverse Reactions

1. Somnolence and Fatigue

May cause dose-dependent somnolence, fatigue, asthenia, sedation, and similar effects.

More likely to occur early in treatment, but may occur throughout the entire treatment period.

Patients should not drive or operate machinery until the drug's effects are known.

Concomitant use with other CNS depressants or alcohol may produce additive effects.

2. Dizziness and Gait Coordination Disturbance

Includes dizziness, vertigo, balance disorder, ataxia, nystagmus, gait disturbance, and similar effects.

May affect daily activities and walking safety.

If symptoms are marked, hazardous activities should be avoided and a doctor consulted.

3. Cognitive Dysfunction

May present as memory impairment, difficulty concentrating, amnesia, confusional state, speech disorder, and similar effects.

May affect thinking speed and orientation.

If related symptoms occur, inform the doctor to assess whether dosage adjustment is needed.

4. Visual Changes

Includes diplopia, blurred vision, and impaired vision.

May affect activities requiring clear vision, such as reading and driving.

If visual symptoms persist or worsen, seek medical attention promptly.

5. Suicidal Ideation and Behavior

Antiepileptic drugs (including cenobamate) may increase the risk of suicidal thoughts or behavior.

Changes in depression, mood abnormalities, suicidal thoughts, or behavior should be monitored.

Patients, family members, or caregivers should report any abnormalities to the doctor immediately.

III. Other Adverse Reactions of Concern and Dosing Principles

1. Discontinuation-Related Risks

Abrupt discontinuation may increase seizure frequency and even lead to status epilepticus.

Generally, the dosage should be gradually reduced over at least 2 weeks, unless rapid discontinuation is required due to a serious adverse event.

Patients should not discontinue the drug on their own; it must be done under a doctor's guidance.

2. Abuse and Dependence Risks

Cenobamate has abuse potential and may produce subjective effects such as euphoria.

It may cause physical dependence; abrupt dose reduction or discontinuation may produce withdrawal symptoms such as insomnia, decreased appetite, depressed mood, tremor, and amnesia.

It should be stored safely to prevent misuse or abuse.

3. Other Precautions

It may reduce the effectiveness of oral hormonal contraceptives; women of reproductive potential should use additional or alternative non-hormonal contraceptive measures.

During treatment, patients should inform their doctor of all concomitant medications and avoid concomitant use with drugs that shorten the QT interval and CNS depressants.

If serious allergic reactions, cardiac symptoms, or neuropsychiatric abnormalities occur, seek medical attention promptly.